Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery

The Medical News ·
Health & Medicine United Kingdom

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the publication of new research in Nature Biotechnology describing an improved calibration framework for deep learning-based genetic perturbation models.

Read original article on The Medical News →

Related news